CARES for Cancer-Related Symptoms

This study is looking at an intervention called CARES, which combines screening and stepped collaborative care, to help people with cancer manage common symptoms like depression, pain, and fatigue. It's being compared to the usual care you would receive, which involves screening and then being referred to a provider. Researchers want to see if CARES improves your overall quality of life. They are also studying how easy or difficult it is to put CARES into practice in real-world settings. You can join if you have a cancer diagnosis, are 18 or older, and can read and write in English. The study is currently unclear about its recruitment status, but plans to enroll 1750 people.

Study design
This is an interventional study comparing CARES to standard of care, planning to enroll 1750 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be measured from enrollment up to 12 months, with a primary measurement at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07183527

Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

Recruiting
NAAges 18+InterventionalSupportive care
University of Pittsburgh
~1,750 participants
Updated 2026-08-10 on ClinicalTrials.gov
What's tested:CARESStandard of Care (SOC)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Functional Assessment of Cancer Therapy-General
Measured over Enrollment to the end of study for participant (12 months). The primary time point is 6 months
+1 more outcome measured
CARES
Standard of Care
1 sites across 1 states
Pennsylvania1
  • Jennifer L Steel, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Cancer
Age 18 years or older
Read and write in English

Exclusion

Evidence of thought disorder
Evidence of delusions
Evidence of hallucinations
Evidence of suicidal ideation with a plan
  • Functional Assessment of Cancer Therapy-GeneralEnrollment to the end of study for participant (12 months). The primary time point is 6 months

    Health Related Quality of Life. A total score (0-108) and subscales scores (0-24 or 0-28) with a higher score reflecting a better quality of life

  • Functional Assessment of Cancer Therapy-GeneralEnrollment to the end of study for participant (12 months). The 12 months outcome will be a measure of maintenance of benefits.

    Health Related Quality of Life. A total score (0-108) and subscales scores (0-24 or 0-28) with a higher score reflecting a better quality of life